Suppliers / G. Pohl-Boskamp GmbH

G. Pohl-Boskamp GmbH

Germany Updated 9 July 2026

G. Pohl-Boskamp GmbH is a finished-dose manufacturer based in Germany. It appears in 11 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, NMPA (CN) and RCETH (BY). Its GMP standing is certified by ZLG (DE), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 September 2023 as VAI.

0
active US DMFs
0
valid CEPs
5
registered plants 1 with an FDA FEI number
11
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 September 2023 VAI US FDA
  • 28 August 2020 VAI US FDA
  • 15 September 2017 VAI US FDA
  • 11 February 2016 VAI US FDA
  • 3 July 2015 NAI US FDA
  • 22 February 2013 VAI US FDA
  • 5 November 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Hohenlockstedt, United Arab Emirates Not on file
Hohenlockstedt, Germany Not on file
Schleswig-Holstein, Germany Not on file
Germany, Germany 3002807915
Daegeling, Germany Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 3 1
NMPA (CN) 2 None
RCETH (BY) 1 None
MPA (SE) 1 None
ANSM (FR) 1 None
EDA (EG) 1 None
ZLG (DE) None 14
EMA None 1

Questions about G. Pohl-Boskamp GmbH

Does G. Pohl-Boskamp GmbH hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for G. Pohl-Boskamp GmbH. It does have 11 filings with 8 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is G. Pohl-Boskamp GmbH FDA-registered?
One site operated by G. Pohl-Boskamp GmbH carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did G. Pohl-Boskamp GmbH's last inspection go?
The most recent inspection on record closed on 14 September 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 7 inspections are on file.
Where does G. Pohl-Boskamp GmbH manufacture?
5 registered sites are on record, in United Arab Emirates and Germany (Hohenlockstedt, Schleswig-holstein and Germany among others). Every site is listed on this page with the register it came from.
Which regulators recognise G. Pohl-Boskamp GmbH's GMP?
Current GMP certificates are on record from ZLG (DE), EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. G. Pohl-Boskamp GmbH comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 September 2023.

Comparable suppliers

AESICA Pharmaceuticals also in Germany Alfred E. Tiefenbacher (GmbH also in Germany Almirall Hermal also in Germany Aqvida also in Germany Aristo Pharma also in Germany

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates